A

Arnaud Pigneux

Centre Hospitalier Universitaire de Bordeaux

ORCID: 0000-0001-5479-0261

415 papers and 11.6k citations.

PubIndex Score74Top 26% · seniorHow it's scored

415Publications

11.6kTotal Citations

First publication: 1995First senior author: 2004

Top publicationsby citations

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Hagop M. Kantarjian, Gabrielle T. Prince et al.|New England Journal of Medicine|2018

Cited by 1.4k

Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

Éric Jourdan, Hervé Dombret, Nicolas Boissel et al.|Blood|2013

Cited by 357

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With<i>NPM1</i>Mutation: A Study by the Acute Leukemia French Association Group

Marie Balsat, Nicolas Boissel, Aline Renneville et al.|Journal of Clinical Oncology|2017

Cited by 292

Prognostic impact of<i>DDX41</i>germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study

Nicolas Duployez, Marie Sébert, Laëtitia Largeaud et al.|Blood|2022

Cited by 80

Overlapping features of therapy-related and de novo <i>NPM1</i>-mutated AML

Jad Othman, Brunangelo Falini, Manja Meggendorfer et al.|Blood|2022

Cited by 43

Indexing the rest of 415 publications…